Records FDA Can Demand During a Cosmetic Safety Issue
What MoCRA gives the FDA authority to request when there's a reasonable belief a cosmetic poses a serious health threat, and how to be ready.
Picture the phone call nobody wants: a customer's rash escalates, a dermatologist gets involved, and someone from FDA has questions. Under MoCRA, that call is not hypothetical for a US cosmetic brand anymore. The Modernization of Cosmetics Regulation Act gave FDA real tools to ask for records when there is reasonable belief a product poses a serious health threat, and the honest answer to "what will they want" is: whatever paper trail proves you knew your product was safe before you sold it.
What triggers the request
FDA does not need a full-blown recall or a confirmed pattern of injuries to start asking questions. A reasonable belief that a cosmetic is adulterated and that the adulteration presents a serious health threat is enough to open the door to a records request. That threshold is intentionally lower than what would be needed for something like a mandatory recall order, because the point of the authority is to let FDA move fast when there's smoke, not wait for a confirmed fire.
The categories of records at stake
MoCRA's broader framework rests on facility registration, product listing, a named responsible person, safety substantiation, and adverse event recordkeeping. When a safety issue triggers a records request, it typically touches several of these at once:
- Safety substantiation. The documentation that supports your claim the product is safe for its intended use. This can include stability data, challenge testing, toxicology references for individual ingredients, or a formal safety assessment.
- Adverse event records. Any reports you have received from consumers, retailers, or your own customer service channel describing a reaction or injury tied to the product, along with what you did in response.
- Product listing information. Confirmation that the formula on file matches what is actually being sold, since a mismatch between your listing and your real formula is its own separate problem.
- Responsible person identification. Records showing who is designated as the responsible person for the product and that this designation was current at the time of sale.
What "being ready" actually looks like
The businesses that handle this well are not the ones scrambling to reconstruct history after a request lands. They are the ones who already have a simple, boring habit: every time a customer reports a reaction, it gets logged, dated, and kept, whether or not the brand thinks the complaint has merit. Every time a formula changes, the safety substantiation file gets updated to match, not left pointing at an old version of the recipe.
A short list worth keeping current at all times:
- A dated log of every adverse event report received, with enough detail to reconstruct what was reported and how it was handled.
- Current safety substantiation tied to the exact formula being sold right now, not a prior version.
- A clear record of who your responsible person is and since when.
- Product listing records that match your actual current formula and label.
| Record type | Why FDA asks for it | Where it usually lives |
|---|---|---|
| Adverse event log | Establishes pattern, timing, and your response | Customer service system or a dedicated log |
| Safety substantiation file | Shows you had a basis to believe the product was safe before selling it | Formulator's files, lab reports, safety assessments |
| Product listing | Confirms the sold formula matches what FDA has on record | Your MoCRA product listing submission |
| Responsible person record | Confirms accountability is assigned and current | Internal compliance records |
Small businesses and the exemption question
MoCRA includes exemptions from registration and listing for some small businesses, but that exemption is narrow and does not blanket-cover every recordkeeping obligation. It is worth checking the current FDA guidance directly rather than assuming a small operation is automatically off the hook for every piece of this, since the details of who qualifies and for which requirements can be specific and are best confirmed at the source.
Keeping this from being a fire drill
The unglamorous truth is that most of what FDA would ask for in a safety issue is the same paperwork a careful brand should already be keeping for its own sake. If your adverse event log is scattered across email threads and a group chat, or if your safety substantiation file is a folder nobody has opened since the original formulation, that is the moment to fix it, not after a letter arrives.
If your main exposure right now is on the notification and ingredient-mapping side rather than the recordkeeping side, that is a different piece of the puzzle. Cosmetic Comply currently handles the Canadian Cosmetic Notification Form workflow, mapping ingredients to INCI names and CAS numbers and screening them against the Hotlist, with US support on the way. For the US side today, the practical move is simply making sure your adverse event log, your safety substantiation, and your product listing all describe the same product, updated at the same time, every time something changes.
Send your ingredients and we take it from here
A short intake form is all it takes to start. Every ingredient gets checked against your market's prohibited and restricted lists, then we file your notification and hand you a number you can track.
Start a filingKeep reading
Common Cosmetics Direct Submission Errors to Avoid
A troubleshooting list of the frequent mistakes that cause rejected or inaccurate MoCRA product listings, and how to fix each one.
Fragrance Allergen Labeling and the April 12 2026 List
What Canada's List 1 fragrance allergen disclosure means for your CNF and label starting April 12, 2026, and how to check your formula now.
How to List Multiple Products Under One Facility
A practical workflow for listing a growing catalog with the FDA under MoCRA without duplicating work or losing track of facility numbers.
Private Label Brands and Who Owns MoCRA Compliance
Working through a private label scenario to pin down who is legally the responsible person under MoCRA when reselling a stock formula.